Infratil FY25 Result—Reality Check
Infratil's current risk levels are high due to leverage and insufficient operating cash flow. CDC's EBITDA growth guidance was disappointing, but...
338 Views
Infratil FY25 Preview—The Long Road to US500m P.a.
CDC remains the dominant driver of Infratil share price and valuation, with a focus expected to shift to Asia and potential positive forward...
390 Views
Infratil - The End of an Era
The sale of Manawa (MNW) to Contact Energy (CEN) has received Commerce Commission clearance, injecting cash and liquidity into Infratil (IFT). IFT...
291 Views
Infratil - CDC—Confidence in Delivery and Contracts
Infratil and its largest investment, CDC, delivered a confident and upbeat investor day, highlighting strong fundamentals with significant new...
358 Views
Infratil - Good Enough
The Catalyst with a capital C arrived. A third-party transaction validated CDC’s valuation, Infratil's (IFT) largest and most important asset.
284 Views